| 1 |
Libé-philippot B, Iwata R, Recupero AJ, Wierda K, Ditkowska M, Gaspariunaite V, Vermaercke B, Peze-heidsieck E, Remans D, Charrier C, Polleux F, Vanderhaeghen P. Human synaptic neoteny requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.. [DOI: 10.1101/2023.03.01.530630] [Reference Citation Analysis]
|
| 2 |
Sauzeau V, Beignet J, Bailly C. Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder. Biomedicines 2022;10:1357. [PMID: 35740379 DOI: 10.3390/biomedicines10061357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Gu M, Pan B, Chen W, Xu H, Wu X, Hu X, Zheng L, Ye Y, Meng Q, Xian G, Zhang Z, Sheng P. SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis. Front Pharmacol 2021;12:794429. [PMID: 35237148 DOI: 10.3389/fphar.2021.794429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Shin B, Hrdlicka HC, Delany AM, Lee SK. Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice. Endocrinology 2021;162. [PMID: 34192317 DOI: 10.1210/endocr/bqab135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Guo Q, Kang H, Wang J, Dong Y, Peng R, Zhao H, Wu W, Guan H, Li F. Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation. J Bone Miner Res 2021;36:2065-80. [PMID: 34155695 DOI: 10.1002/jbmr.4399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Liu Y, Dou Y, Yan L, Yang X, He B, Kong L, Smith W. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study. Biosci Rep 2020;40:BSR20200407. [PMID: 32578854 DOI: 10.1042/BSR20200407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Xu R, Shen X, Xie H, Zhang H, Liu D, Chen X, Fu Y, Zhang P, Yang Y, Cheng J, Jiang H. Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss. Theranostics 2021;11:5491-510. [PMID: 33859759 DOI: 10.7150/thno.55041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Lorenzo J. Sexual Dimorphism in Osteoclasts. Cells 2020;9:E2086. [PMID: 32932615 DOI: 10.3390/cells9092086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 9 |
Tang W, Xiao L, Ge G, Zhong M, Zhu J, Qin J, Feng C, Zhang W, Bai J, Zhu X, Wei M, Geng D, Wang Z. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway. J Cell Mol Med 2020;24:11972-83. [PMID: 32896108 DOI: 10.1111/jcmm.15821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Niimi T. Roles of Slit Ligands and Their Roundabout (Robo) Family of Receptors in Bone Remodeling. Adv Exp Med Biol 2021;21:143-54. [PMID: 32986130 DOI: 10.1007/5584_2020_586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
